The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse serves as a model of basal ganglia injury and Parkinson's disease. The present study investigated the effects of MPTP-induced lesioning on associative memory, conditioned fear, and affective behavior. Male C57BL/6 mice were administered saline or MPTP and separate groups were evaluated at either 7 or 30 days post-lesioning. In the social transmission of food preference test, mice showed a significant decrease in preference for familiar food 30 days post-MPTP compared to controls. Mice at both 7 and 30 days post-MPTP lesioning had increased fear extinction compared to controls. High Performance Liquid Chromatography analysis of tissues homogenates showed dopamine and serotonin were depleted in the striatum, frontal cortex, and amygdala. No changes in anxiety or depression were detected by the tail suspension, sucrose preference, light-dark preference, or hole-board tests. In conclusion, acute MPTP lesioning regimen in mice causes impairments in associative memory and conditioned fear, no mood changes, and depletion of dopamine and serotonin throughout the brain.
Introduction
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor impairment including slowness of movement, rigidity, balance dysfunction, and resting tremor. However, disabling non-motor symptoms are seen in 30% to 60% of patients and include semantic and episodic memory loss, impairment of executive function, depression, and anxiety (Cummings, 1992; Hornykiewicz, 1963; Pillon et al., 1989a; Walsh and Bennett, 2001) . A number of brain regions have been implicated in influencing non-motor behavioral symptoms including the basolateral amygdala, nucleus accumbens, frontal cortex, and the raphe nucleus (Ressler and Nemeroff, 2000; Walsh and Bennett, 2001) . Together with dopamine, serotonin from the dorsal and medial raphe nuclei is thought to play a central role in regulating affective behavior. Perturbation of serotonin neurotransmission in normal individuals can lead to depression, anxiety, and memory impairment (Mann and Yates, 1986; Mann, 1999; Pillon et al., 1989b) . Patients with PD develop central serotonergic dysfunction, such as low cortical serotonin levels and degeneration of the dorsal raphe nucleus (Agid et al., 1989; Cummings, 1992; Gotham et al., 1986; McCance-Katz et al., 1992; Scatton et al., 1983) . 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) neurotoxicity in the substantia nigra pars compacta (SNpc) produces severe dopamine depletion in mice and nonhuman primates, and causes significant decrease of serotonin across multiple brain regions. For example, chronic MPTP treatment in monkeys decreases levels of serotonin in the caudate nucleus, putamen, nucleus accumbens, hypothalamus, and cortical areas (Frechilla et al., 2001; Perez-Otano et al., 1991; Pifl et al., 1991; Russ et al., 1991) . In mice, acute administration of MPTP leads to serotonin loss in the striatum and frontal cortex one week after lesioning (Rousselet et al., 2003) .
The purpose of the current study was to evaluate the effects of MPTP lesioning on associative memory, conditioned fear, depression, and anxiety, since this neurotoxic injury leads to depletion of dopamine and serotonin in brain regions important for these behaviors. After acute MPTP lesioning, mice were tested at 7 days (greatest dopamine depletion) and 30 days (partial recovery of striatal dopamine). We used established mouse tests for associative memory (social transmission of food preference), fear conditioning, anxiety (light-dark preference, hole board), and depression (tail suspension, sucrose preference). Brain regions involved in control of affective behavior (frontal cortex, amygdala, and the raphe nucleus), as well as the basal ganglia (ventral mesencephalon, striatum), were examined
